katherine trial updates for her2-positive breast cancer
Published 4 years ago • 1.1K plays • Length 6:04Download video MP4
Download video MP3
Similar videos
-
14:35
sabcs 2023 her2 breast cancer highlights – aphinity sub-analysis, katherine update, her2climb-02
-
1:18
dr. hamilton discusses the katherine trial in her2 breast cancer
-
1:56
dr. rimawi discusses katherine trial in her2 breast cancer
-
1:31
dr. geyer on the rationale for the katherine trial in her2-positive breast cancer
-
3:50
update from kaitlin for high-risk her2-positive early breast cancer
-
5:46
adjuvant trastuzumab emtansine vs paclitaxel and trastuzumab for her2-positive breast cancer
-
5:42
updates on managing her2-positive early breast cancer
-
1:00
case study - 21 "breast cancer: causes, symptoms, and treatment l common cancer in women."
-
1:09
latest updates in her2-positive metastatic breast cancer: the nala and sophia trials
-
6:53
treating early her2 breast cancer: katherine
-
2:02
katherine trial: t-dm1 cuts her2-positve invasive breast cancer recurrence
-
1:18
expert discusses practice-changing data from katherine trial in breast cancer
-
6:37
improved idfs for breast cancer patients who received trastuzumab emtansine
-
1:29
dr. hamilton on the results of the katherine trial in her2 breast cancer
-
4:09
impact of the katherine trial on early-stage her2 bc
-
5:42
adjuvant t-dm1 for her 2 breast cancer: critical data from the katherine study
-
1:21
katherine trial tests trastuzumab emtansine in breast cancer recurrence
-
4:01
management of her2 positive metastatic breast cancer treatment algorithm
-
1:28
dual her2 blockade in patients with her2-positive breast cancer after pcr